N/a
-Sep 17 2020: Presents Data at ESMO Confirming Efficacy of Onvansertib and Durability of Response in KRAS-Mutated Metastatic Colorectal Cancer (mCRC)
-SPY pattern: Consolidation
-Intraday pattern: Mountain
-Other notes: N/a
Strategy: First test long of 8.2
Confluence: N/a
Strike Zone: 8.25 - 8.15
Sizing (lots + emergency): 250
Risk (stop / Rs): N/a
Didn't clearly define my risk so when It stuffed above 8.2 then started going down I panic a little bit. Didn't realize it bounced from the demand line until after I stopped out, would have been a good add spot and a great trade otherwise, lessons learned...
Lessons Learned: Don't stop out in front of Whole $ or demand trend lines!
Execution detail:
Date/time | Symbol | Side | Price | Position |
---|---|---|---|---|
2020-09-17 12:57:07 | CRDF | buy | $8.210 | long |
2020-09-17 12:57:07 | CRDF | buy | $8.210 | long |
2020-09-17 12:59:37 | CRDF | sell | $8.145 | long |
2020-09-17 12:59:37 | CRDF | sell | $8.140 | long |
2020-09-17 12:59:37 | CRDF | sell | $8.140 | 0 |
You need to log into your Tradervue account to leave a comment. If you don't have one,
it takes
just a few seconds to sign up, and it's free!